2015 May 27
Heroes in the fight against breast cancer
Scientific and clinical advances in the treatment of triple negative breast cancer were recently highlighted with an award for Linda Vahdat, M.D. Read more
2015 May 27
Seeking a second line of defense
Bishoy Faltas, M.D., has been awarded a 2015 Young Investigator Award from the American Society of Clinical Oncology to pursue his study of platinum-resistant bladder cancer. Read more
2015 May 26
Better mouse model enables colon cancer research
A team of engineers and clinicians has created a comprehensive mouse model of exactly how colorectal tumors behave in real life. Read more
2015 May 26
Hospice services can better promote bereavement adjustment for spousal caregivers
Holly Prigerson offers suggestions for ways to improve how hospices treat both patients and their grieving spouses in a commentary for JAMA Internal Medicine. Read more
2015 May 26
Pioneering Personalized Medicine
Lewis C. Cantley leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination. Read more
2015 May 25
Taking the Next Step in a Storied Career
Harold Varmus, M.D., talks to the ASCO Post about his new roles at Weill and the New York Genome Center Read more
2015 May 21
Doctor's personal tie to treating lung cancer
Thoracic surgeon Brendon Stiles, M.D., saves patients from the same disease that claimed the life of his father. Read more
2015 May 21
New study describes genomic landscape of castration-resistant prostate cancer
Researchers at Weill are part of an international team that has published insight into what drives advanced prostate cancer. Read more
2015 May 20
Cantley elected to EMBO
Meyer director Lewis Cantley, Ph.D., has been elected to the prestigious European life sciences academy EMBO. Read more
2015 May 18
Study Discovers How Pancreatic Cancer Spreads to the Liver
A team led by David Lyden has illuminated the precise molecular steps that enable pancreatic cancer to spread to the liver. Read more
2015 May 13
Stem cell therapy research gets $15.7m boost
A consortium of scientists and transplant clinicians led by Shahin Rafii and Joseph Scandura has been awarded a $15.7 million, four-year research grant. Read more
2015 May 08
Mason feted for epigenetics work
Christopher Mason was honored as a finalist for the second annual Pershing Square Sohn Prize for Young Investigators in Cancer Research Read more
2015 May 07
Clinical focus: Follicular lymphoma
John Leonard, M.D., comments about follicular lymphoma treatments in a series of MedPage Today articles. Read more
2015 May 07
Elevated breast cancer risk across the BMI spectrum
Andrew Dannenberg, M.D. speaks about the association between breast inflammation and breast cancer. Read more
2015 May 07
Safety switches may redeem potent CAR T cancer therapies
Laurie H. Glimcher provides commentary on new data reporting therapies that involve using CAR T cells, white blood cells taken from the body and genetically modified to have the cancer-spotting traits of antibodies. Read more
2015 May 02
Molecular Mutations in MDS
Gail J. Roboz, M.D., director of Weill's Leukemia Program, discusses molecular mutations in myelodysplastic syndromes (MDS). Read more
2015 Apr 30
Lis elected to American Academy of Arts and Sciences
Meyer Cancer Center member John Lis, the Barbara McClintock Professor of Molecular Biology and Genetics based in Ithaca, was among three Cornell faculty members recently elected to the American Academy of Arts and Sciences. Read more
2015 Apr 29
Uncovering new functions of a gene implicated in cancer growth opens new therapeutic possibilities
Research by David Lyden into the immune suppression function of the Inhibitor of Differentiation 1 gene may lead to new therapies for melanoma and other advanced-stage cancers. Read more
2015 Apr 29
Esophageal cancer: What happens after 5 years?
Esophageal cancer patients who survived five years after surgery were likely to survive longer despite recurrence risk, according to a new study by Brendon Stiles, M.D. Read more
2015 Apr 28
Precision Medicine: Working Toward Custom-Fitted Cures
Mark Rubin speaks to U.S. News and World Reports about the future of precision medicine Read more
